Tap Block and Cesarean Delivery: Efficacy and Consumption of Postoperative Drugs (TAPFANS)

S. Anna Hospital

Status: Unknown

Conditions: Cesarean Delivery

Treatments: Other: intravenous analgesia; Procedure: Tap block

Study type: Interventional

Funder types: Other

Identifiers

NCT02801968

CEIIAV1574

Details and patient eligibility

About

The purpose of this study is to determine the efficacy of Tap block after cesarean delivery as a component of multimodal analgesia and evaluation of postoperative drugs consumption.

Enrollment: 62 estimated patients

Sex: Female

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• age > 18 years
• written consent
• anesthesiologist's assent on preoperative evaluation

Exclusion criteria

• age< 18 years
• uncooperative patients
• written consent not obtained
• local anesthetic allergy
• BMI > 35

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

62 participants in 2 patient groups

Tap block

Experimental group

Description:

Tap block with ropivacaine 2 mg/kg at the end of cesarean delivery. Postoperative analgesia with acetaminophen and tramadol plus NSAIDs (nonsteroidal anti-inflammatory drugs) as rescue dose.

Treatment:

Other: intravenous analgesia

Procedure: Tap block

control group

Active Comparator group

Description:

Postoperative analgesia after cesarean delivery with acetaminophen and tramadol plus NSAIDs (nonsteroidal anti-inflammatory drugs) as rescue dose.

Treatment:

Other: intravenous analgesia